AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
Active, not recruiting · NCT05247684 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC | Resectable Non-small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-07-29 | NCT05247684 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akeso | 89 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 23 |